Related Experiment Video
Updated: Apr 30, 2026

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
Signal Detection Analysis of Hypnotic-induced Respiratory Depression
Saki Hideshima1, Rintaro Sogawa2, Yuki Nakano1
1Department of Pharmacy, Saga University Hospital, Nabeshima, Japan.
Benzodiazepine receptor agonists (BZRAs) and melatonin receptor agonists (MRAs) were linked to respiratory depression. Newer hypnotics like dual orexin receptor antagonists (DORAs) showed no significant association in this large-scale analysis.
Area of Science:
- Pharmacology
- Clinical Toxicology
- Sleep Medicine
Background:
- Benzodiazepine receptor agonists (BZRAs) are common hypnotics.
- Emerging evidence suggests newer hypnotics, including melatonin receptor agonists (MRAs) and dual orexin receptor antagonists (DORAs), may also pose risks for respiratory depression.
- The clinical association between hypnotic use and respiratory depression requires further investigation.
Purpose of the Study:
- To investigate the association between the use of various hypnotics and the risk of respiratory depression.
- To compare the risk of respiratory depression across different classes of hypnotics, including BZRAs, MRAs, and DORAs.
Main Methods:
- Analysis of 733,296 reports from the Japanese Adverse Event Reporting Database (April 2004-September 2023).
- Calculation of reporting odds ratios (RORs) and 95% confidence intervals (CIs) for respiratory depression associated with each hypnotic class.
- Adjustment for potential confounders including sex, age, reporting year, concomitant medications, and medical history.
Main Results:
- A significant association between respiratory depression and Benzodiazepine receptor agonists (BZRAs) (adjusted ROR=1.34; 95% CI=1.20-1.49) and Melatonin receptor agonists (MRAs) (adjusted ROR=2.03; 95% CI=1.56-2.64) was found.
- No significant association was observed for non-benzodiazepines and dual orexin receptor antagonists (DORAs) (adjusted ROR=0.94; 95% CI=0.70-1.27).
- Stratified analyses indicated BZRAs were associated with respiratory depression across all ages, while MRAs showed an association irrespective of opioid use.
Conclusions:
- The risk of respiratory depression varies among different hypnotic medications.
- Beyond BZRAs, Melatonin receptor agonists (MRAs) represent a potential risk for respiratory depression.
- Clinical vigilance is warranted when prescribing hypnotics, particularly BZRAs and MRAs, due to their association with respiratory depression.
More Related Videos
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Related Concept Videos
Acute Respiratory Failure-IV
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...